The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 335:1182-1189 October 17, 1996 Number 16
NextNext

Apoptosis in Myocytes in End-Stage Heart Failure
Jagat Narula, M.D., Ph.D., Nezam Haider, Ph.D., Renu Virmani, M.D., Thomas G. DiSalvo, M.D., Frank D. Kolodgie, Ph.D., Roger J. Hajjar, M.D., Ulrich Schmidt, M.D., Marc J. Semigran, M.D., G. William Dec, M.D., and Ban-An Khaw, Ph.D.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Heart failure can result from a variety of causes, including ischemic, hypertensive, toxic, and inflammatory heart disease. However, the cellular mechanisms responsible for the progressive deterioration of myocardial function observed in heart failure remain unclear and may result from apoptosis (programmed cell death).

Methods We examined seven explanted hearts obtained during cardiac transplantation for evidence of apoptosis. All seven patients had severe chronic heart failure: four had idiopathic dilated cardiomyopathy, and three had ischemic cardiomyopathy. DNA fragmentation (an indicator of apoptosis) was identified histochemically by in situ end-labeling as well as by agarose-gel electrophoresis of end-labeled DNA. Myocardial tissues obtained from four patients who had had a myocardial infarction one to two days previously were used as positive controls, and heart tissues obtained from four persons who died in motor vehicle accidents were used as negative controls for the end-labeling studies.

Results Hearts from all four patients with idiopathic dilated cardiomyopathy and from one of the three patients with ischemic cardiomyopathy had histochemical evidence of DNA fragmentation. All four myocardial samples from patients with dilated cardiomyopathy also demonstrated DNA laddering, a characteristic of apoptosis, whereas this was not seen in any of the samples from patients with ischemic cardiomyopathy. Histologic evidence of apoptosis was also observed in the central necrotic zone of acute myocardial infarcts, but not in myocardium remote from the infarcted zone. Rare isolated apoptotic myocytes were seen in the myocardium from the four persons who died in motor vehicle accidents.

Conclusions Loss of myocytes due to apoptosis occurs in patients with end-stage cardiomyopathy and may contribute to progressive myocardial dysfunction.


Source Information

From Massachusetts General Hospital and Harvard Medical School, Boston (J.N., T.G.D., R.J.H., U.S., M.J.S., G.W.D., B.-A.K.); Northeastern University, Boston (J.N., N.H., B.-A.K.); and the Armed Forces Institute of Pathology, Washington, D.C. (R.V., F.D.K.).

Address reprint requests to Dr. Khaw at 205 Mugar, Northeastern University, 360 Huntington Ave., Boston, MA 02115.

Full Text of this Article


Related Letters:

Apoptosis in the Heart
Saraste A., Voipio-Pulkki L.-M., Parvinen M., Pulkki K., Narula J., Dec G. W., Virmani R., Khaw B.-A.
Extract | Full Text  
N Engl J Med 1997; 336:1025-1026, Apr 3, 1997. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.